Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03182140 · ClinicalTrials.gov registry record
KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 1,134
- Enrollment target
NCT03182140 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 1,134 participants.
The verdict
NCT03182140 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 1,134 participants
- Enrollment target
Study Summary
The main goal of this non-interventional study (NIS) is to evaluate user satisfaction with Kyleena in a real-life setting and to identify factors which influence user satisfaction, taking into account previously used contraceptive methods and reasons for use of Kyleena.
Interventions
- DRUG Kyleena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,134 participants |
| Start Date | 2017-07-06 |
| Est. Completion | 2020-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03182140
The ClinicalTrials.gov registry entry for NCT03182140 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kyleena is the first listed.
NCT03182140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03182140 about?
NCT03182140 is a clinical study titled "KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method". The main goal of this non-interventional study (NIS) is to evaluate user satisfaction with Kyleena in a real-life setting and to identify factors which influence user satisfaction, taking into account previously used contraceptive methods and reasons for use of Kyleena.
What is the current status of trial NCT03182140?
This trial is currently completed. The enrollment target is 1,134 participants. The study started on 2017-07-06. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT03182140?
The interventions under investigation include: Kyleena (DRUG).
Who is sponsoring clinical trial NCT03182140?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.